Centre- Versus Home-based Exercise for MCI and Early Dementia (CHIME)

May 27, 2019 updated by: University of Waterloo

How do we Get People With MCI and Dementia to be Physically Active?

The study is a proof-of-concept, double-blinded randomized, parallel group trial to compare the effectiveness of centre-based and home-based physical activity in helping people with MCI and early dementia meet physical activity recommendations. The primary outcome is achievement of physical activity recommendations. Secondary outcomes include cost-effectiveness and improvements in health and function.

Study Overview

Detailed Description

The aim of this trial is to compare the effectiveness of center-based versus home-based physical activity delivery among people with MCI and early dementia and to understand the influence of person and setting characteristics.

OBJECTIVES:

Primary: To compare the effectiveness of centre-based versus home-based physical activity delivery among people with MCI or early dementia, as measured by percent achievement of physical activity guidelines.

Secondary:

(i) To determine the influence of person- and setting-specific factors. (ii) To estimate the cost-effectiveness of centre-based and home-based physical activity.

Exploratory:

i) To compare the effect of centre- and home-based physical activity on other outcomes.

ii) To explore whether participants consider certain aspects of the program to be important to program effectiveness.

METHODS:

The investigators will conduct a 3-month proof-of-concept, double-blinded randomized, parallel group trial to compare the effectiveness of centre-based and home-based physical activity in helping people with MCI and early dementia meet physical activity recommendations.

Participants will be randomized to one of two physical activity delivery options.The goal of both arms will be to have participants reach physical activity guidelines by the end of the 3-month intervention.

Participants who are randomized to centre-based physical activity will attend physical activity programming at a centre (University of Waterloo or Toronto Rehabilitation Institute) once per week for one hour. Additional physical activity will be prescribed at home.

Participants who are randomized to the home-based physical activity will received a physical activity prescription to be completed at home. They will also receive monthly support calls to assess achievements and barriers and to adjust the prescription.

All assessors will be blinded to group allocation.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4N 3M5
        • Sunnybrook Research Institute
      • Waterloo, Ontario, Canada, N2L3G1
        • University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of MCI or mild dementia
  • Mini-Mental State Examination (MMSE)>=23 or Montreal Cognitive Assessment (MoCA)>=18
  • 50 years or older
  • Stable pharmaceutical regimen >=2 months
  • Be able to travel to centre
  • Have a care partner or significant other to support home-based exercise
  • Ability to walk >=2 minutes
  • Adequate English to understand exercise training
  • Adequate hearing and vision for cognitive tests
  • Able to comply with assessment and training schedule
  • Be screened safe for exercise by a physician or certified exercise physiologist

Exclusion Criteria:

  • Current moderate or high intensity exercise >=3 times per week
  • Unstable cardiovascular disease that precludes exercise
  • Musculoskeletal impairments that limit ability to walk
  • Pain or other co-morbidities that would limit exercise
  • Behavioural issues that would limit exercise training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Centre-based physical activity
People with Mild Cognitive Impairment (MCI) and early dementia will receive centre-based physical activity for one hour each week for three months, plus at-home prescribed exercise.
Participants will come to a centre (University of Waterloo or Toronto Rehabilitation Institute) for a one-hour, small group exercise class each week. The classes will include progressive aerobic and resistance exercise. They will be prescribed additional exercise to be performed independently (either at home or in the community).
Experimental: Home-based exercise
People with Mild Cognitive Impairment (MCI) and early dementia be prescribed at-home prescribed exercise and will received monthly support phone calls.
Participants will be prescribed aerobic and resistance exercise to be performed independently (either at home or in the community). They will receive monthly phone calls to discuss achievements and barriers and to tje adjust exercise prescription.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Achievement of Physical Activity
Time Frame: 3 months
Percent achievement of physical activity recommendations (150min/wk of moderate or high intensity physical activity) as objectively measured using an activity monitor.
3 months
Change in physical activity
Time Frame: baseline to 3 months
Change in physical activity as objectively measured using an activity monitor.
baseline to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness
Time Frame: 3 months
Cost of resource utilization per minute change in physical activity.
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cognitive function as characterized by Alzheimer's Disease Assessment Scale - Cognition (ADAS-Cog)
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in cognitive function as characterized by the Stroop task
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in cognitive function as characterized by the Trail making task
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in cognitive function as characterized by the semantic fluency
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in physical function as characterized by the Short Physical Performance Battery (SPPB) scores
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in quality of life as measured with the EuroQol five dimensions questionnaire (EQ-5D)
Time Frame: baseline to 3 months
Change in continuous scores
baseline to 3 months
Change in mood as measured with the Neuropsychiatric Inventory Questionnaire (NPI-Q) (depression/dysphoria, anxiety, apathy/indifference scales)
Time Frame: baseline to 3 months
Change in scores, number meeting screening criteria for depression
baseline to 3 months
Change in daily function as characterized using the 6-item Disability Assessment for Dementia (DAD-6)
Time Frame: baseline to 3 months
Change in score
baseline to 3 months
Change in body mass index (BMI)
Time Frame: baseline to 3 months
Change in score
baseline to 3 months
Change in waist circumference
Time Frame: baseline to 3 months
Change in score
baseline to 3 months
Change in blood pressure
Time Frame: baseline to 3 months
Change in number with high blood pressure (>140 systolic blood pressure (SBP), >90 diastolic blood pressure (DBP))
baseline to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

March 1, 2019

Study Registration Dates

First Submitted

April 7, 2016

First Submitted That Met QC Criteria

May 12, 2016

First Posted (Estimate)

May 17, 2016

Study Record Updates

Last Update Posted (Actual)

May 29, 2019

Last Update Submitted That Met QC Criteria

May 27, 2019

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Centre-based exercise

Subscribe